Eliminating Needles:Doctor Developing Vaccine Patch

Article

WASHINGTON, DC-A former US Army doctor may have discovered a new method of distributing medication-one that could eliminate tears from pediatricians' offices and provide the world with a less expensive method of vaccinating the public.

Gregory Glenn has accidentally discovered a method of delivering vaccines by using skin patches. His biotechnology company, Iomai, is developing the idea Glenn found while working with mice.

In an experiment to determine whether liposomes could serve as a delivery vehicle for topical vaccines, Glenn moistened a mouse's skin with a cholera toxin solution. The toxin penetrated the skin and provoked an immune reaction.

This discovery alone overturned the dogma that huge molecules, like those of cholera toxin, couldn't penetrate the outer layer of skin. It also gave Glenn an idea. If a minute quantity of toxin mixed with vaccines can effectively immunize an animal when painted on the skin, a patch mixed with the same ingredients may do the same for humans.

Glenn and his scientists at Iomai have showed this works with the cholera germ Vibrio cholerae and the intestinal bug Escherichia coli .

His preliminary research has brought in millions of dollars from international investors. Elan Corp of Dublin, a medical company, has invested $6 million. Mitsubishi Corp of Japan has given $2 million and a Maryland development fund has invested $1 million.

Glenn is primarily excited about the development of a vaccination patch because it could revolutionize health conditions in developing countries that often struggle to find money for expensive injections.

Information from www.washingtonpost.com

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.
 Futuristic UV Sanitizer with Sleek Design on a white background.  (Adobe Stock 1375983522 by Napa)